JGA Suspends Taiyo Pharmaceutical Membership
This article was originally published in PharmAsia News
Executive Summary
The Japan Generic Association March 29 announced it would suspend Taiyo Pharmaceutical membership for one year because of a manufactuirng violation uncovered in March